Trials of antihypertensive therapies in children

Blood Pressure Monitoring

Volumn 4, Issue 3-4, 1999, Pages 189-192

  Wells, Thomas G ^a  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

Ambulatory blood pressure measurement; Antihypertensives; Blood pressure measurement; Children; Hypertension; Pediatrics

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; ANTIHYPERTENSIVE AGENT; BETAXOLOL; BISOPROLOL FUMARATE; BISOPROLOL FUMARATE PLUS HYDROCHLOROTHIAZIDE; CANDESARTAN HEXETIL; CARVEDILOL; DIURETIC AGENT; ENALAPRIL MALEATE; FELODIPINE; FOSINOPRIL; LABETALOL; LISINOPRIL; MOEXIPRIL; NITRENDIPINE; QUINAPRIL; VERAPAMIL;

BLOOD PRESSURE MONITORING; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; DRUG APPROVAL; DRUG INDICATION; DRUG MARKETING; DRUG PACKAGING; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERTENSION; METHODOLOGY; ORAL DRUG ADMINISTRATION; PEDIATRICS; PRIORITY JOURNAL; REFERENCE VALUE; SIDE EFFECT; STANDARDIZATION;

EID: 0032718073     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-199903000-00016     Document Type: Conference Paper

References (14)

1. Wells TG. Underserved therapeutic classes: examples which should not be ignored in infants and children. Drug Inf J 1996; 30:1179-1186.
2. Farrar HC, Wells TG, Kearns GL. Pediatric clinical pharmacology: reclaiming the therapeutic orphan. Exp Opin Invest Drugs 1996; 5:7-13.
3. Wells TG, House M, Belsha CW, Berry PL. Isradipine treatment of hypertension in children. J Investig Med 1995; 43:59A.
4. Khattak S, Rogan JW, Saunders EF, Theis JGW, Arbus GS, Koren G. Efficacy of amlodipine in pediatric bone marrow transplantation. Clin Pediatr 1998; 37:31-36.
5. Wells TG, Sinaiko AR. Antihypertensive efficacy and pharmacokinetics of nitrendipine in children. J Pediatr 1991; 118:638-643.
6. Myers MG. Ambulatory blood pressure monitoring in the assessment of antihypertensive therapy. Blood Press Monit 1999; 4:185-188.
7. Hornsby JL, Mongan PF, Taylor AT, Treiber FA. 'White coat' hypertension in children. J Fam Pract 1991; 33:617-623.
8. Sample written request for oral antihypertensives. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. March 26, 1999. (Available at http://www.fda.gov/cder/pediatric/htnwr.htm).
9. Task Force on Blood Pressure Control in Children. Report of the Second Task Force on Blood Pressure Control in Children - 1987. Pediatrics 1987; 79:1-25.
10. List of approved drugs for which additional pediatric information may produce health benefits in the pediatric population. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Docket No. 98N-0056, 1998. (Available at http://www.fda.gov/cder/peddrugsfinal.htm).
11. Approved drug products to which FDA has issued a written request for pediatric studies under Section 505A of the Federal Food, Drug, and Cosmetic Act. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, March 26, 1999. (Available at http://www.fda.gov/cder/pediatric/wrlist.htm).
12. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients; final rule. Federal Register, Vol. 63. No. 231, pp. 66631-66672, December 2, 1998.
13. Guidance for industry. Qualifying for pediatric exclusivity under Section 505A of the Federal, Food. Drug, and Cosmetic Act. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Docket No. 98D-0265, June 30, 1998.
14. Committee on Drugs. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics 1995; 95:286-294.